Citigroup Inc Accelerate Diagnostics, Inc Transaction History

Citigroup Inc

  • $153 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$0.54 - $1.41 $981 - $2,563
-1,818 Reduced 78.7%
492 $0
Q1 2022

May 12, 2022
SELL
$1.4 - $5.15 $9,105 - $33,495
-6,504 Reduced 73.79%
2,310 $3,000
Q4 2021

Feb 10, 2022
BUY
$4.27 - $6.97 $18,941 - $30,918
4,436 Added 101.32%
8,814 $46,000
Q3 2021

Nov 10, 2021
BUY
$5.31 - $8.25 $23,247 - $36,118
4,378 New
4,378 $26,000

Others Institutions Holding AXDX

# of Institutions
3
Shares Held
549K
Call Options Held
0
Put Options Held
0
View Full List

About Accelerate Diagnostics, Inc

AXDX Quotes by TradingView
  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email